|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D14.1 |
Benign neoplasm of larynx
|
D141 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 64.83%
|
19.40%
|
7.13%
|
3.22%
|
1.87%
|
1.06%
|
0.77%
|
0.73%
|
0.33%
|
0.04%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D14.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2704
|
INJ, PROPOFOL, 10 MG |
831
|
32,268
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
814
|
1,064
|
|
J3010
|
FENTANYL CITRATE INJECTION |
778
|
1,177
|
|
J2405
|
ONDANSETRON HCL INJECTION |
775
|
3,202
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
744
|
7,035
|
|
31541
|
LARYNSCOP W/TUMR EXC + SCOPE |
585
|
589
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
458
|
5,820
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
404
|
813
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
352
|
353
|
|
J0171
|
ADRENALIN EPINEPHRINE INJECT |
306
|
8,266
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
305
|
712
|
|
J7120
|
RINGERS LACTATE INFUSION |
293
|
365
|
|
J0330
|
SUCCINYCHOLINE CHLORIDE INJ |
261
|
1,685
|
|
J2001
|
LIDOCAINE INJECTION |
239
|
2,248
|
|
31579
|
LARYNGOSCOPY TELESCOPIC |
195
|
195
|
|
31575
|
DIAGNOSTIC LARYNGOSCOPY |
184
|
184
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
180
|
566
|
|
31572
|
LARGSC W/LASER DSTRJ LES |
169
|
169
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
151
|
620
|
|
82962
|
GLUCOSE BLOOD TEST |
146
|
182
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D14.1 related to the following DRG Codes:
011-013
154-156
|
